J. Perunicić

发表

Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI data.

I. Mrdović, L. Savic, M. Ašanin, 2013, The Canadian journal of cardiology.

High-dose streptokinase in the treatment of acute massive pulmonary embolism complicated with cardiogenic shock, respiratory arrest and ventricular fibrillation.

I. Mrdović, J. Perunicić, R. Lasica, 2005, Vojnosanitetski pregled.

Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.

I. Mrdović, L. Savic, M. Ašanin, 2007, American heart journal.

Temporal variations at the onset of spontaneous acute aortic dissection.

I. Mrdović, J. Perunicić, N. Milic, 2006, International heart journal.

Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial.

I. Mrdović, L. Savic, M. Ašanin, 2013, Journal of interventional cardiology.

Predicting 30-day major adverse cardiovascular events after primary percutaneous coronary intervention. The RISK-PCI score.

Zorana Vasiljevic, Nikola Kocev, I. Mrdović, 2013, International journal of cardiology.

Simple risk algorithm to predict serious bleeding in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: RISK-PCI bleeding score.

I. Mrdović, L. Savic, M. Ašanin, 2013, Circulation journal : official journal of the Japanese Circulation Society.

Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.

I. Mrdović, L. Savic, M. Ašanin, 2013, International journal of cardiology.

Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial

I. Mrdović, L. Savic, M. Ašanin, 2013, Heart and Vessels.

Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI study.

Zorana Vasiljevic, I. Mrdović, L. Savic, 2009, Journal of interventional cardiology.

Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial

I. Mrdović, L. Savic, M. Ašanin, 2012, Coronary artery disease.

Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register

I. Mrdović, L. Savic, M. Ašanin, 2014, European heart journal. Acute cardiovascular care.

Modern clinical retrospective on ventricular rhythm disturbances in acute myocardial infarction: Latest treatment mode according to the valid recommendations

I. Mrdović, L. Savic, J. Perunicić, 2015 .

69 obstacles in the Diagnostics and Therapy of Heparin-induced Thrombocytopenia

B. Stojanović, J. Perunicić, I. Antonijevic, 2015 .

Adequate evaluation of thrombocytopenias as a prerequisite to effective cardiac patient treatment

J. Perunicić, V. Kanjuh, G. Koracevic, 2012 .

Obstacles in the diagnostics and therapy of heparin-induced thrombocytopenia.

B. Stojanović, J. Perunicić, I. Antonijevic, 2010, Srpski arhiv za celokupno lekarstvo.

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome

I. Mrdović, J. Perunicić, M. Djokic, 2008, Journal of Thrombosis and Thrombolysis.

Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin‐induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin

J. Perunicić, M. Kovac, Z. Vasiljević, 2006, Journal of clinical apheresis.

Need for more intensive treatment of patients with acute pulmonary embolism caused by heparin-induced thrombocytopaenia Type II.

J. Perunicić, Z. Vasiljević, B. Čalija, 2005, European heart journal.

Incidence of Hyperhomocysteinemia and Mthfr C677T Polymorphism Among Young Patients with Acute Myocardial Infarction

J. Perunicić, Z. Vasiljević, N. Majkić-Singh, 2009 .

Incidenca Hiperhomocisteinemije I Polimorfizam Mthfr C677T Kod Mladih Bolesnika SA Akutnim Infarktom Miokarda

J. Perunicić, Z. Vasiljević, N. Majkić-Singh, 2009 .

Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary intervention.

I. Mrdović, L. Savic, M. Ašanin, 2010, The Journal of invasive cardiology.

Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism—From Modern Recommendations to Clinical Application

A. Ristic, L. Savic, M. Ašanin, 2022, Pharmaceuticals.

Right ventricular takotsubo cardiomyopathy.

I. Mrdović, M. Ašanin, J. Perunicić, 2010, Journal of the American College of Cardiology.

Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction

I. Mrdović, M. Ašanin, J. Perunicić, 2005, European journal of heart failure.

Myocardial Reinfarction in a Patient with Coronary Ectasia

I. Mrdović, M. Ašanin, J. Perunicić, 2004, Cardiology.

Transient left ventricular apical ballooning complicated by a mural thrombus and outflow tract obstruction in a patient with pheochromocytoma.

I. Mrdović, M. Ašanin, J. Perunicić, 2008, Texas Heart Institute journal.

The Long‐Term Risk of Stroke in Patients with Acute Myocardial Infarction Complicated with New‐Onset Atrial Fibrillation

I. Mrdović, M. Ašanin, J. Perunicić, 2009, Clinical cardiology.

Significance of recurrences of new atrial fibrillation in acute myocardial infarction.

I. Mrdović, M. Ašanin, J. Marinković, 2006, International journal of cardiology.

Heparin induced thrombocytopenia type II and myocardial infarction: Two case reports

J. Perunicić, M. Kovac, P. Miljić, 2004 .

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

[Intramural hematoma in acute aortic syndrome].

J. Perunicić, R. Lasica, D. Simic, 2005, Medicinski arhiv.

Prognostic Significance of Atrial Fibrillation in Lower Limb Amputee Patients.

M. Ašanin, J. Marinković, J. Perunicić, 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) SYSTEM

T. Potpara, A. Ristic, D. Lovic, 2015 .

Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary intervention.

L. Savic, M. Ašanin, J. Marinković, 2012, Journal of interventional cardiology.

Carvedilol increases copper-zinc superoxide dismutase activity in patients with acute myocardial infarction.

David R. Jones, J. Perunicić, D. Blagojević, 2007, Basic & clinical pharmacology & toxicology.

Transient Left Ventricular Apical Ballooning Complicated by a Mural Thrombus and Outflow Tract Obstruction

M. Ašanin, J. Perunicić, Z. Vasiljević, 2008 .

Early and Late Mortality Predictors in Patients with Acute Aortic Dissection Type B

M. Ašanin, J. Perunicić, R. Lasica, 2022, Cardiology research and practice.

HYPERHOMOCYSTEINEMIA IN PATIENTS WITH PULMONARY EMBOLISM

M. Lačković, J. Perunicić, M. Kocica, 2010 .

Incidence of Hyperhomocysteinemia Among Patients With Acute Myocardial Infarction Younger Than 45 Years

J. Perunicić, N. Majkić-Singh, D. Mirković, 2007 .

Therapeutic hypothermia and primary percutaneous coronary intervention in comatose survivor of out-of-hospital cardiac arrest due to acute myocardial infarction

M. Ašanin, J. Perunicić, M. Tomasevic, 2012 .